cell therapy manufacturing

cell therapy manufacturing

featured image of Revolutionary Cell-Therapy Tech: Scalability Made Simple

Revolutionary Cell-Therapy Tech: Scalability Made Simple

BIOT

🔍 MFX is revolutionizing cell therapy manufacturing with its scalable Cyto Engine Stack, securing funding for a 2025 release. 🧪📈💰🔬

featured image of Revolutionizing Cell and Gene Therapy: Challenges and Opportunities

Revolutionizing Cell and Gene Therapy: Challenges and Opportunities

BIOT

Redefining Cell and Gene Therapy Navigation 📰 explores the challenges and opportunities in this rapidly evolving sector 🧬. It emphasizes the need for improved regulatory frameworks and collaboration 💼💪🏼🌍.

featured image of FDA Approves Game-Changing Solid Tumor Cell Therapy!

FDA Approves Game-Changing Solid Tumor Cell Therapy!

BIOT

🚀 Iovance receives FDA approval for groundbreaking solid tumor cell therapy! 💪🔬 Stay tuned for more exciting updates! 🌟

featured image of Boost AAV Genome Production with RevIT Enhancer!

Boost AAV Genome Production with RevIT Enhancer!

BIOT

🚀 Boost AAV genome production with RevIT™ AAV Enhancer! 🧬💰 Increase titers, streamline workflows, and save costs in gene therapy manufacturing.

featured image of Revolutionary Partnership Expands Cell Therapy Development

Revolutionary Partnership Expands Cell Therapy Development

BIOT

📰 Multiply Labs and Thermo Fisher join forces to revolutionize cell therapy production! 💼🔬 Accelerating development and commercialization for patients. 🏭

featured image of AZ Accelerates Cell Therapy Production with FasTCAR: Faster Cheaper and Accessible

AZ Accelerates Cell Therapy Production with FasTCAR: Faster Cheaper and Accessible

BIOT

📢 AstraZeneca teams up with FasTCAR to fast-track cell therapy production, revolutionizing accessibility and affordability for patients. 🚀

featured image of Samsung Biologics and LegoChem unite to revolutionize cancer treatment

Samsung Biologics and LegoChem unite to revolutionize cancer treatment

BIOT

🔍 Samsung Biologics teams up with LegoChem to advance ADCs, combining antibodies and drugs to target cancer cells. 🔬 Collaboration leverages manufacturing expertise and ADC development technology for better cancer treatment options.

featured image of Game-Changing Novo Catalent Deal Revolutionizes CGT Outsourcing

Game-Changing Novo Catalent Deal Revolutionizes CGT Outsourcing

BIOT

📢 Get ready for a game-changer! The Novo Catalent deal is about to shake up the CGT outsourcing space. 💥🧪💼

featured image of Evotec's Breakthrough: Expanding HIV Antibody Deal

Evotec’s Breakthrough: Expanding HIV Antibody Deal

BIOT

📰 Evotec expands anti-HIV antibody deal with ABL to develop and manufacture neutralizing antibodies against HIV. Just-Evotec Biologics to develop third antibody and provide manufacturing services for Phase I clinical study. Partnership aims to deliver new HIV therapies. 💉🌍

featured image of Regulatory Spotlight on Cleaning Validation in Biotech

Regulatory Spotlight on Cleaning Validation in Biotech

BIOT

📢 Cleaning validation is receiving increased attention from regulatory agencies in the biotechnology industry. 🧪🔬🏭🔍💼🔒